Top in GI: Gut microbiome and COVID-19, GERD symptoms

A recent study showed that gut microbiome composition may impact the severity of COVID-19. It was the top story in gastroenterology last week.

An analysis investigating the benefits of an anti-reflux lifestyle in reducing gastroesophageal reflux disease symptoms was another top story.

Read these and more news in gastroenterology below:

Gut microbiome composition impacts severity of COVID-19

Correlation between gut microbiota composition, cytokine levels and inflammatory markers among patients with COVID-19 demonstrated the gut microbiome is linked with the severity of COVID-19, according to a study in Gut. Read more.

Anti-reflux lifestyle leads to decreased risk for GERD symptoms in women

Women who adhered to an anti-reflux lifestyle had a decreased risk for gastroesophageal reflux disease symptoms, possibly preventing up to 40% of symptoms that occur weekly, according to study results. Read more.

Link between gut microbiome, diet may reduce risk for health problems

A healthy diet may be linked with gut microbes that correlate with a lower risk for developing conditions including obesity, type 2 diabetes and CVD, according to a report published in Nature Medicine. Read more.

Mass screening program finds high prevalence of undiagnosed pediatric celiac disease

Mass screening identified a high prevalence of celiac disease among children, according to study results. Read more.

The race is on for medical treatment of NASH

Nonalcoholic steatohepatitis is the second leading indication for liver transplantation in the United States but there are currently no FDA-approved treatments available. Read more.